December 8, 2025Blood

Different graft-vs-host disease prophylaxis strategy for allogeneic hematopoietic stem cell transplantation in adults with chronic active EBV infection

View Full Paper

Ask AI

Bookmark

Graft-vs-host disease prophylaxis improved outcomes in adults with chronic active EBV infection.
Patients receiving anti-thymocyte globulin plus post-transplant cyclophosphamide had better survival rates.
Analysis of transplant outcomes and complications highlighted the importance of effective GVHD strategies.
The findings suggest further exploration of prophylaxis strategies to enhance long-term survival post-transplant.

Discussion

No takes yet. Share an insight, caveat, or question.

Retrospective review shows improved progression-free survival with anti-thymocyte globulin and PTCy in adults with chronic active EBV infection.

Wei et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Retrospective review shows improved progression-free survival with anti-thymocyte globulin and PTCy in adults with chronic active EBV infection.